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Building a stem cell-based primate uterus
Sophie Bergmann 1,2,3, Magdalena Schindler1,2,3, Clara Munger1,2,3,
Christopher A. Penfold 1,2,3,4✉ & Thorsten E. Boroviak 1,2,3✉
The uterus is the organ for embryo implantation and fetal development. Most current models
of the uterus are centred around capturing its function during later stages of pregnancy to
increase the survival in pre-term births. However, in vitro models focusing on the uterine
tissue itself would allow modelling of pathologies including endometriosis and uterine can-
cers, and open new avenues to investigate embryo implantation and human development.
Motivated by these key questions, we discuss how stem cell-based uteri may be engineered
from constituent cell parts, either as advanced self-organising cultures, or by controlled
assembly through microfluidic and print-based technologies.
The primary function of the uterus is to provide a suitable environment for the embryo toimplant and gestate to full term. Recent single-cell transcriptional atlases of the uterusduring the menstrual cycle1,2 and of the maternal–foetal interface during the first tri-
mester of pregnancy in human3,4, provide comprehensive roadmaps to drive forward the
development of stem cell-based models. The goal of such stem cell-based uterus models is to
engineer a defined, flexible, and scalable system to address fundamental questions of repro-
ductive biology. Major topics include mechanisms and pathologies of embryo implantation,
embryogenesis, crosstalk between the developing embryo and the mother, and pathologies of the
female reproductive tract. The first trimester of pregnancy is a particularly dynamic and critical
stage when the embryo organises the body plan before the foetal growth phase in the second and
third trimesters. Although complex in vitro models capable of complete recapitulation of the
structure and function of the uterus may be necessary for a clinical setting to increase survival
chances of premature fetuses5, such models would lack the scalability and experimental flexibility
required for drug discovery and genetic screening.
In this review, we discuss the construction of stem cell-based uterus models to illuminate the
earliest stages of human embryogenesis and associated pathologies. We outline the develop-
mental origin of the uterus and consider its anatomy, function, and diseases. Building on recent
breakthroughs in organoid culture, we highlight the constituent components from which a stem
cell-based uterus may be engineered and propose a modular approach to assembling uterine
models. We discuss approaches based on self-organisation as well as controlled assembly, either
through microfluidic or print-based methodologies and conclude how these technologies can be
used to tackle questions about implantation failure and key pathologies of the uterus.
Developmental origin of the uterus
In mammals, the uterus originates from the intermediate mesoderm which is positioned between
the paraxial and lateral plate mesoderm after gastrulation6 (Fig. 1, week 3). At Carnegie stage
(CS)10, the embryo folds to form the intraembryonic coeloms which are lined by lateral plate
mesoderm and intermediate mesoderm, wherein the inner lining of the coeloms is the coelomic
epithelium7 (Fig. 1, week 5). A subset of intermediate mesoderm cells undergoes mesenchymal-
to-epithelial transition to form the nephric duct along the body. This transition requires Pax2
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and Pax8, which induce expression of Lhx1 (Lim1)8, an impor-
tant transcription factor of the urogenital system in both mouse
and human9,10. The nephric ducts are required for the develop-
ment of adult kidneys, the ureter, and the genital tract. The
initially central portion of the nephric duct is known as the
Wolffian (mesonephric) ducts.
Morphogenetic rearrangements at CS12–16 lead to the inser-
tion of the Wolffian ducts into the cloaca, the precursor of the
bladder11,12. Intermediate mesoderm‑derived coelomic epithelial
cells invaginate to form the Müllerian (paramesonephric) ducts at
CS14–17, which elongate caudally along the Wolffian ducts at
CS18–23. In mouse, the Müllerian and Wolffian ducts express
Lhx1 and Wnt signalling is required for Wolffian duct
elongation13,14. Histological studies of human embryos suggest
that this morphogenetic process is conserved11,15. At CS23,
Wolffian and Müllerian ducts together form the bipotential
genital tract16. In males, the Müllerian ducts degenerate and the
Wolffian ducts persist to form male reproductive organs. In
females, it is the Müllerian ducts that develop into the female
reproductive tract while the Wolffian ducts degenerate6. In either
case, sex determination is controlled by gene expression from the
X and Y chromosomes17,18.
Development of the uterus at week 8–9 commences with the
fusion of the Müllerian ducts, which will undergo morphogenesis
to form the uterus, fallopian tubes, cervix, and upper vaginal tract.
Müllerian duct fusion in humans results in one central uterine
cavity, in contrast to rodents, where Müllerian duct fusion is less
extensive to allow the formation of two separated uterine
horns11,16. At week 16, the developing human uterus starts to
form glands in the endometrium. Endometrial glands gradually
increase complexity and develop branches within the stroma until
birth and will continue to develop postnatally until puberty11.
This contrasts with mouse development where glands are formed
exclusively after birth19,20. Nevertheless, both human and mouse
endometrial gland formation requires WNT signalling21,22. Pre-
natal uterine development concludes with the formation of
myometrium at week 22 and the uterus assumes its adult shape23.
The final steps of human uterus development occur during
puberty when the uterus further matures under the influence of
sex steroid stimulation and initiates the menstrual cycle.
Anatomy and function of the uterus
The uterus is located within the pelvic area, between the bladder
and the rectum. In humans, it is on average about 7 cm long and
weighs around 60 g in the non-pregnant state (non-gravid),
extending to up to five-fold in size during pregnancy (gravid).
The uterine body contains a triangular uterine cavity with the
isthmus leading to the cervix, which connects to the vaginal
opening (Fig. 2a). The uterus is supported by uterine ligaments
which, together with the ovaries and fallopian tubes, form the
appendages of the uterus. Externally, the uterus consists of thick,
smooth muscle bundles, the myometrium, and is covered by
serous tissue termed perimetrium (Fig. 2b).
The endometrium is the inner mucosal layer, which surrounds
the uterine cavity and is comprised of stroma and uterine glands.
The endometrium changes cyclically in terms of function and
appearance during the menstrual cycle (Fig. 2c). Apes, Old World
monkeys, and some New World monkeys undergo a menstrual
cycle characterised by external bleeding due to shedding of the
outermost layer (menses)24. Most other mammalian species
experience an oestrous cycle, in which the uterus undergoes
remodelling throughout the cycle without shedding25. During
human menstruation, only the endometrial functionalis layer
facing the uterine cavity is shed while the basalis layer situated
towards the myometrium remains unaffected by hormonal
changes (Fig. 2b)26–28. The human menstrual cycle lasts on
average 28 days and is orchestrated by steroidal hormones,
including oestrogen and progesterone (Fig. 2c). Following men-
ses, oestrogen is secreted by the ovaries, stimulating endometrial
proliferation, which rebuilds the shed surface layer in the pro-
liferative, or follicular, phase. The egg is released around day 14 of
the cycle during ovulation. Progesterone secreted in the ovaries
from the remnants of the follicle which contained the released
egg, the corpus luteum, stimulates the thickening of the uterine
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Fig. 1 Developmental origin of the uterus. The development of the human uterus is shown in situ (top panel) and cross-sections (bottom panel).
Gastrulation and primitive streak formation occur in Carnegie stage (CS)7 embryonic disc 3 weeks post-fertilisation, leading to the formation of
intermediate mesoderm at CS 8. At CS10, the embryo has folded and established the intraembryonic coeloms. The nephric ducts develop from the
mesodermal coelomic epithelium between CS12 and CS13. The central parts constitute the Wolffian ducts (WD). Concomitantly, the Müllerian ducts
invaginate from the coelomic epithelium adjacent to the nephric duct and elongate towards the cloaca. By CS22–23, the bipotential gonads are fully
established in proximity to the kidneys. Both are connected to the WDs and Müllerian ducts, ultimately leading to the cloaca. In female fetuses of around
week 8–9, the WDs degenerate, and the Müllerian ducts fuse to form the uterine body and the upper vaginal tract. The uterus acquires its final shape at
around 24 weeks post-fertilisation.
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progesterone signals from the corpus luteum induce stromal cells
to undergo a transformation, termed decidualisation, in pre-
paration for embryo implantation. In case of successful fertilisa-
tion, foetal trophoblast and maternal corpus luteum cooperatively
sustain hormone levels to maintain the pregnancy, otherwise,
with progesterone levels declining, the outermost endometrial
functionalis layer is lost as a result of menstruation26–28.
The functionalis and basalis layers of the endometrium are
composed of four tissue compartments (Fig. 2d):
1. Epithelial compartment: The luminal epithelium establishes
the boundary to the uterine cavity and is remodelled during
the menstrual cycle to become receptive for the implanting
embryo. Uterine glands consist of connected glandular
epithelium, which extends towards the myometrial border
and cyclically change shape from tubular, in the prolif-
erative phase, to coiled, in the secretory phase. The luminal
epithelium is lost during menstruation, and the stroma is
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Fig. 2 Anatomical structure of the uterus. a The cavity of the human uterine body connects to the ovaries by the fallopian tubes. b The uterine wall
consists of the endometrium, the smooth muscular myometrial layer, and the outermost perimetrium. The endometrial epithelium forms the border to the
cavity (luminal epithelium) and deep-reaching endometrial glands (glandular epithelium) which are embedded in the stroma. Only the endometrial
functionalis layer is shed during menstruation at the beginning of the human uterine cycle (c), while the non-hormone-responsive basalis layer remains
intact. Oestrogen produced by the developing follicle in the ovaries induces the growth and proliferation of endometrial tissue during the proliferative
(follicular) phase. Ovulation and release of the egg from the ovaries occur mid-cycle, which leads to increased progesterone levels during the secretory
(luteal) phase. Degradation of the corpus luteum and decreasing hormone levels induce menses and re-start the uterine cycle if no embryo implants into
the uterine wall. d The endometrium can be functionally distinguished into four compartments, which change throughout the uterine cycle. The luminal
epithelium of the epithelial compartment (1) is shed during menses and rebuilt by differentiating epithelial progenitor cells migrating from uterine glands.
The luminal epithelium becomes pre-receptive but avoids pre-mature attachment of an embryo by the formation of a highly charged glycocalyx layer.
Uterine glands grow in size and increase secretion towards the secretory phase while changing shape to become coiled. The luminal epithelium grows
apical cellular protrusions (pinopodes), which increases receptivity and allows embryo attachment and implantation. Decidualisation occurs during the
secretory phase in the stromal compartment (2) and assists in the preparation of the endometrium for implantation. Mesenchymal stem cells surrounding
spiral arteriole (specialised uterine blood vessels) pericytes differentiate to become secretory. Concomitantly, stromal fibroblasts undergo mesenchymal-
to-epithelial transition (MET) under the influence of progesterone (P4) and convert to decidualised, secretory fibroblasts. Spiral arteries in the vascular
compartment (3) branch from basal arteries, which supply the endometrial basalis layer during menses, when arteries of the functionalis layer are
extensively remodelled or lost. Angiogenesis drives the formation of spiral arteries towards the secretory phase to increase the blood supply of the upper
endometrium in preparation for embryo implantation. The uterine immune compartment (4) is a highly flexible system. Immune aggregates consisting of
B-cells, T-cells and macrophages form and reside in the upper parts of the functional layer, maintaining the balance between defence against pathogens
and external threats and sustaining the protective microbiome barrier necessary for uterine health. During pregnancy, the immune compartment provides
maternal tolerance to an embryo which induces attachment to the uterine wall. If no successful implantation occurs, immune cells such as uterine natural
killer (uNK) cells and macrophages are recruited to remove decidualised cells.
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transformation of glandular epithelial cells, which migrate
towards the cavity and rebuild the luminal epithelium26.
2. Stromal compartment: The endometrial stroma is a
connective tissue consisting of fibroblasts and extracellular
matrix. In the mid-secretory phase, fibroblast-like stromal
cells differentiate into rounded epithelioid-like cells in
response to progesterone, a process termed decidualisation.
Human decidualisation begins when stromal cells sur-
rounding spiral arterioles in the upper two-thirds of the
endometrium enlarge 6 days after ovulation in preparation
for a potential pregnancy.
3. Vasculature compartment: Basal arteries branching from
the uterine radial arteries supply the basalis layer and
produce a capillary bed. This supports the functionalis layer
viability during menstruation29, when its spiral arteries are
extensively remodelled and partially lost. After menstrua-
tion, spiral arteries are rebuilt by angiogenesis. Progesterone
levels control the blood flow, which increases in the
secretory phase, and decreases towards the onset of
menstruation. In the absence of progesterone, the blood
supply to the spiral arteries stops, causing the stroma to
become necrotic and ultimately leads to the onset of
menstruation.
4. Immune compartment: Accounting for an estimated
10–15% of the stromal compartment, the endometrial
immune compartment provides protection against patho-
gens and balances the commensal microbiome30,31. Impor-
tantly, it adopts an immunosuppressive state during
embryo implantation and acquires maternal tolerance in
reaction to hormonal changes32. The composition of the
immune compartment changes significantly during the
menstrual cycle33, including a substantial increase in
uterine natural killer cells following ovulation, which
represent the dominant uterine leucocytes during
pregnancy.
Pregnancy is established when a competent blastocyst implants
into the receptive endometrium. Embryo implantation begins
with adplantation and apposition of the blastocyst at the site of
implantation, allowing trophoblast cells to attach (Fig. 3a).
Multinucleated syncytiotrophoblast penetrates the luminal epi-
thelium of the endometrium, crosses the basement membrane,
and invades the stromal compartment. In human and Great Apes,
the conceptus burrows into the endometrium, resulting in an
interstitial implantation, while in Old World and New World
monkeys, the embryo remains within the uterine cavity and
undergoes superficial implantation34,35 (Fig. 3b). After the initial
stages of embryo implantation, human cytotrophoblast and dif-
ferentiated extravillous trophoblast further invade and induce
remodelling of the spiral arteries and maternal tissues. Decid-
ualisation plays an important role in mediating the invasiveness
of the trophoblast cells and subsequent placentation via the
secretion of chemoattractants. Whilst in humans, decidualisation
occurs naturally during the menstrual cycle and develops further
following implantation, in Old World and New World monkeys
decidualisation is initiated post-implantation and may be less
extensive, or proceed more gradually34,35. In Old World mon-
keys, following initial attachment, but prior to the invasion,
proliferation and hypertrophy of the epithelium occur at the
periphery of the invading syncytiotrophoblast. The endometrial
epithelium adjacent to the implantation site remodels its gland-
ular appearance and undergoes a transformation into epithelial
plaques35,36. Epithelial plaque formation does not occur in
humans or Great Apes but has been observed in New World
monkeys, including the marmoset34,37. The mechanisms con-
trolling the different degrees of trophoblast invasion in monkeys
and apes remain an intriguing open question and are highly
relevant for pathologies affecting placental invasion.
Pathologies of the gravid and non-gravid uterus
Human embryo implantation is an inherently inefficient process.
Only around 25% of blastocysts implant into the uterus, repre-
senting a major hurdle to natural conception38–40 and rate-
limiting step in assisted reproductive technologies41,42. In 2% of
pregnancies, the embryo implants outside of the endometrium,
often into the fallopian tubes, resulting in an ectopic pregnancy43.
This can be life-threatening for the mother if left untreated and
requires termination of the pregnancy. In about 2–8% of preg-
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Fig. 3 Embryo development within the uterus and uterine pathologies. a The stages leading to human interstitial embryo implantation and marmoset
superficial implantation (b) are shown from left to right. The blastocyst arrives in the uterine cavity and hatches from the surrounding zone pellucida by day
5 post-fertilisation. It then moves along the uterine epithelium until it reaches a receptive environment provided by pinopodes before the inner cell mass
(ICM) aligns towards the uterine epithelium (adplantation). The outer extraembryonal trophoblast cells of the blastocyst connect to the uterine cells
(apposition) and penetrate through the luminal epithelium (adhesion). Concomitantly, the ICM differentiates into extraembryonal hypoblast and
embryonal epiblast, which induce lumenogenesis. Trophoblast comprises of several layers of proliferative cytotrophblast (dark blue) and terminally
differentiated, multinucleated syncytiotrophoblast (purple) which continue invasion into the endometrium towards nutrition-providing uterine glands and
blood vessels, by degrading the extracellular matrix of the decidualised stroma. The human embryo is fully embedded in maternal endometrium following
implantation. In contrast, the embryo is not fully engulfed by endometrium in superficial implantation (b) but stays within the uterine cavity. Common
pathologies (c) associated with early stages of pregnancy are the failure of an embryo to implant into the uterine cavity wall, or ectopic pregnancy, when
the embryo does not reach the uterine cavity for implantation, and instead implants mostly within the uterine tube. d Abnormal invasiveness causes
placental deficiencies leading to placenta accreta spectrum disorders, caused by excessive trophoblast invasion, or pre-eclampsia, as a result of insufficient
trophoblast invasion.
REVIEW ARTICLE COMMUNICATIONS BIOLOGY | https://doi.org/10.1038/s42003-021-02233-8
4 COMMUNICATIONS BIOLOGY |           (2021) 4:749 | https://doi.org/10.1038/s42003-021-02233-8 | www.nature.com/commsbio
leading to pre-eclampsia44,45, which is characterised by high
maternal blood pressure. Pre-eclampsia can result in seizures and,
consequently is one of the leading causes of maternal morbidity
and mortality worldwide with severe risks for both mother and
the unborn child46. In 1 in 533 births47, excessive trophoblast
invasion into deep maternal uterine tissues impairs separation of
the placenta from the uterine wall following delivery48 (Fig. 3c).
These placenta accreta spectrum disorders cause major obstetric
maternal haemorrhage and sometimes require an emergency
hysterectomy (removal of the uterus. Placenta accreta spectrum
disorders remain a major cause of maternal death, with a mor-
tality rate of up to 7%49. Antenatal diagnosis is limited to ultra-
sound methods and MRI, resulting in up to two-thirds of cases
remaining undiagnosed until delivery. These pathologies are
responsible for only a fraction of all pregnancy loss, and it is
estimated that up to 1 in 4 pregnancies will result in a
miscarriage40–42. Advanced in vitro models of the uterus should
provide a strong basis for investigating the mechanisms of
maternal–embryo interactions, and subsequent pregnancy loss.
Pathologies of the non-pregnant uterus include conditions
relating to menstruation (dysmenorrhoea, menorrhagia), mus-
culature (uterine prolapse), and genetic malformations (uterine
septum, bicornuate uterus). There are around 9400 cases of
endometrial cancers each year in the UK, with a 92% 5-year
survival rate when diagnosed at the earliest stage compared to
15% when diagnosed at stage four50. The most common treat-
ment for endometrial cancers is hysterectomy, potentially com-
bined with radiotherapy or chemotherapy. Hysterectomy may
also be necessary for other forms of cancers, including ovarian
and cervical cancers, and gynaecological sarcoma. Endometriosis
is a chronic condition affecting 10% of the female population51. It
occurs when cells of the endometrium grow outside of the
uterus52, most commonly in the ovaries and fallopian tubes.
These cells remain hormone-responsive during the menstrual
cycle, resulting in inflammation of the surrounding regions and
eventual formation of scar tissues. Although there are strong
heritability53,54, the risk factors and mechanisms remain unclear.
There is currently no cure and treatment is limited to surgery,
hormone treatment, and pain relief. Stem cell-based disease
models have the potential to increase our mechanistic under-
standing of these pathologies, and thus advance clinical and
regenerative treatments.
Building blocks for a stem cell-based uterus
The assembly of a stem cell-based uterus requires devel-
opmentally authentic cell lines as constituent parts (Fig. 4). Pre-
vious in vitro models of endometrium rely on cancer-derived cell
lines55 which are likely to be compromised due to their carci-
nogenic origin. Consequently, we suggest that the construction of
stem cell-based uteri should be based on either pluripotent stem
cells (PSCs) or patient-specific primary cultures, depending on
the research objective.
The differentiation of PSCs into the endometrial epithelium
and stromal-like cells presents a promising avenue (Fig. 4). The
first differentiation attempts were based on co-culture of PSCs
with primary endometrial cultures56,57. However, these condi-
tions were poorly defined, and the resulting cells were not fully
characterised. Miyazaki et al. addressed this problem by differ-
entiating human-induced PSCs (iPSCs) into endometrial stromal
fibroblast-like cells in a 14-day embryoid-body-based approach in
defined conditions58. The protocol closely follows in vivo endo-
metrium development: iPSCs progress from primitive streak
through intermediate mesoderm, coelomic epithelium and
Müllerian duct-like stages. The first part of the differentiation is
based on a protocol used to generate kidney progenitor cells59.
Intermediate mesoderm-like cells express markers including
LHX1 and PAX2. The fact that the intermediate mesoderm-like
cells derived by this protocol can be used to make both kidney
and endometrial-like cells, lends credibility to the developmental
authenticity of the system. BMP inhibition prevents the acquisi-
tion of renal identity, while WNT activation is required for
Müllerian duct and uterine gland development in vivo13,14,60,61.
The resulting endometrial stromal fibroblast-like cells were
hormone-responsive and resembled primary endometrial stromal
cells as determined by RNA sequencing (RNA-seq). This protocol
provides an encouraging starting point for iPSC-derived models
of human endometrium.
Primary cultures of human adult tissue represent an alternative
approach for building a stem cell-based uterus. Endometrium
biopsy-derived epithelial and stromal cultures can be maintained
in vitro and respond to hormonal stimuli59,62,63. Purified endo-
metrial cell cultures have been used to understand physiological
and pathological processes, including trophoblast invasion64.
However, endometrium-derived primary culture offers limited
potential for use in in vitro models since they cannot be propa-
gated in vitro for many passages and tend to differentiate62,63.
Recent advances in organoid culture demonstrate that when
epithelial cells from endometrial primary cultures are dissociated,
separated from the stromal compartment, and seeded into a 3D-
extracellular matrix scaffold, they are capable self-organisation
into hollow spheres formed by a single layer of columnar
epithelium65–69. These spheres are called endometrial organoids
as they recapitulate several physiological characteristics of the
endometrium, and RNA-seq shows organoids share many simi-
larities with in vivo endometrial glands66,70. In contrast to two-
dimensional primary cultures, endometrial organoids can be
readily propagated, stay genetically and phenotypically stable, and
retain the capacity to respond to hormonal stimuli65,66,70,71.
Strikingly, when exposed to sex hormones, such as progesterone
or oestrogen, organoids develop characteristics of early pregnancy
and are able to recapitulate the menstrual cycle65,66,70. Single-cell
profiling identified several sub-populations in endometrial orga-
noids, including proliferating, secretory, ciliated, and putative






















Fig. 4 The cellular building blocks of a stem-cell-based uterus.
Appropriate cellular models of the epithelial compartment of the uterus (1)
can be established as organoids and progenitor cell cultures, which can be
derived from primary patient cells. The stromal compartment (2) can be
founded by induced pluripotent stem cells (iPSC) or embryonal stem cells
(ESC) cultures, or mesenchymal stem cells (MSC) derived from primary
cell culture. The vasculature compartment (3) can be derived from iPSCs,
ESCs or directly from primary cells, and immune cells of the endometrium
build the immune compartment (4).
COMMUNICATIONS BIOLOGY | https://doi.org/10.1038/s42003-021-02233-8 REVIEW ARTICLE
COMMUNICATIONS BIOLOGY |           (2021) 4:749 | https://doi.org/10.1038/s42003-021-02233-8 | www.nature.com/commsbio 5
generate either secretory or ciliated epithelial cells, which is
consistent with the proposition of a progenitor population
in vivo66. Overall, endometrial organoids represent the first step
towards 3D-modelling of the endometrium and offer a sustain-
able source of endometrial epithelial cells71–74.
Assembly approaches
Due to the broad range of topics relating to uterine pathologies
and maternal–embryo interactions, a single endometrial culture
system is unlikely to address all biological questions of interest.
Instead, a modular approach is required, with stem cell-based
uteri variously assembled from the minimal components neces-
sary to answer key questions74,75. Such modularity is advanta-
geous due to its flexibility, whilst the use of minimal component
sets avoids unnecessary confounding factors that may obscure
interpretation and confers a degree of scalability. Here, we focus
on three key approaches: (i) self-organising cultures to model
early implantation; (ii) controlled assembly approaches to model
trophoblast invasion, placentation, and embryo maintenance, or
pathologies of the uterus; (iii) scaffold-based approaches that may
be used to model pathologies of the uterus, with potential clinical
implications.
Self-organising co-cultures
The co-culture of embryos alongside endometrial epithelial
monolayers has long been suggested as a model for implantation
and to gauge mechanisms of apposition and competence of
blastocysts for maternal–embryo interactions76–84. Similarly, the
culture of embryos with endometrial stromal cells provides
opportunities for investigating aspects of trophoblast invasion at
the earliest stages82,85–89. Multi-layered co-cultures combining
epithelial and stromal cells offer a more complete model of early
implantation90–92 but are limited by the availability of uterine
tissue and embryo samples. Whilst issues with the availability of
maternal tissues may be mitigated by appropriate community
resources, such as biobanks, embryos are likely to remain the key
bottleneck to these applications.
Endometrial organoids65,66,70,93 represent a suitable advance-
ment over monolayer cultures, allowing for more complete
modelling of endometrial tissues including the characteristic
glandular structure. Since changes in endometrial vasculature
represent a phenotypic readout of implantation, the incorpora-
tion of vasculature within organoid models would provide an
important improvement (Fig. 5a). Blood vasculature has pre-
viously been induced in co-cultures of PSC-derived endothelial
cells with pericytes94,95 or the introduction of mesodermal pro-
genitor cells into organoid cultures96,97 (reviewed in ref. 98). It
remains to be seen if such protocols can be adapted to allow
survival and self-organisation of vascularised endometrial
organoids.
Human blastocyst or first-trimester placenta-derived tropho-
blast stem cells provide an exciting avenue to model the extra-
embryonic compartment99–102. Trophoblast stem cells are
capable of self-renewal and differentiation into syncytiotropho-
blast and trophoblastic vesicles103,104. The latter may provide
suitable surrogate models for human blastocysts to overcome the
ethical and practical limitations associated with human embryo
research. Indeed, the culture of trophoblast spheroids alongside
endometrial epithelial cells105–116 or stromal cells89,108,117–119 has
already been demonstrated. A key step forward would therefore
be the co-culture of vascularised endometrial organoids with
trophoblast organoids (Fig. 5a). Hurdles to overcome include
identification of suitable media that allow for survival and
development of these divergent organoid systems, and issues
arising from the reversal of the apicobasal polarity, with microvilli
facing towards the organoid lumen, rather than outwards where
contact with the embryo-surrogate would occur (Fig. 5a).
PSC-based approaches have also emerged as useful platforms
for modelling embryonic and extraembryonic tissues, and may
soon represent useful proxies for embryos. In mouse, co-culture
of embryonic and extraembryonic cell types allows the formation
of embryo-like structures reminiscent of pre-implantation
blastocysts120,121 and post-implantation mouse embryos122,123
(reviewed in ref. 124). A combination of embryonic and extra-
embryonic tissues is likely to be required to faithfully recapitulate
maternal–embryo interactions, rather than extraembryonic tro-
phoblast tissues alone (Fig. 5a). Indeed, secreted ligands from the
mouse inner cell mass (ICM) induce proliferation in adjacent
polar trophectoderm125,126 and play essential roles in implanta-
tion. This might be of particular relevance for primate develop-
ment, where the blastocyst implants with the ICM oriented
towards the endometrium127,128. Continuing advances in the field
will provide stem cell-based embryo models, which are bound to
outperform models based on trophoblast organoids alone. Ulti-
mately, the establishment of robust stem cell-based embryos in
human and non-human primates will be an essential goal for the
development of realistic and scalable models of early pregnancy.
Selective incorporation of components of the immune
system129–131 represents an additional advantage of assembled
stem cell-based uteri. The importance of immune cells in pre-
venting diseases33,132 as well as their immunomodulatory role
during pregnancy132–139 is well established, and the distribution
of immune cells is highly dynamic within the menstrual cycles
(reviewed in ref. 33). The inclusion of immune components into
organoid models would be an asset to delineate mechanisms of
immune tolerance, albeit at the expense of increased complexity.
Careful consideration should be given as to which components of
the immune system to include in order to retain tractability of the
organoid approaches. The abundance of uterine natural killer
cells within the uterus during pregnancy may present a natural
starting point. Due to the plasticity of components of the immune
system care must be taken to minimise undesired transdiffer-
entiation of immune components in culture. Fluorescence label-
ling and live-cell imaging will allow tracking of immune cell
movements and, combined with single-cell profiling endpoint
analysis, will provide candidate regulators for immunomodula-
tory functions of the uterus.
Controlled structural assembly: layered deposition and
organ-on-a-chip
Decidualisation and placentation represent protracted biological
processes that extend over large spatial scales. Trophoblast
invasion, which is an important part of placentation, has been
quantified using invasion assays. Traditional approaches include
the culture of trophoblast cells in Matrigel-coated trans-well
inserts with their invasiveness being monitored. These techniques
are limited in scope and incapable of capturing the complex
interplay between trophoblast and maternal tissues. Full model-
ling of trophoblast invasion, placentation, and pathologies such as
placenta accreta, requires tissue constructs more akin to the
maternal interface.
Print-based technologies have been suggested for a variety of
tissue constructions140,141 including muscle142 and neural
tissues143. These approaches are based on the layered deposition
of appropriate gel-embedded cells or bio-inks by 3D printing
technologies144. The increased spatial scale of these tissue con-
structs over organoids may require the integration of functional
vasculature for oxygen and nutrient supply. Blood vasculature has
already been induced in Matrigel and hyaluronic acid (HA)-based
hydrogels145,146 and the deposition of epithelial-cell-laden
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Fig. 5 Engineering of a stem cell-based uterus. a Co-culture systems to model the uterus during embryo implantation. Advances include vascularisation of
endometrial organoids and integration of immune components. The co-culture of vascularised organoids alongside embryo should allow apposition assays
if the polarity of organoids can be inverted. b Apposition, adhesion and trophoblast invasion could be modelled in complex tissue constructs engineered by
layered deposition of 3D cell-embedded gels using 3D printing. c Automatised culture can be obtained by using organ-on-a-chip technology, allowing high-
throughput screening of patient-derived uterine cells for co-culture and cell-invasion assays, but also enable linear stacking of multiple components of the
female reproductive tract on-a-chip, such as ovarian and fallopian tube-cell containing chips. d Pathologies associated with the human uterus, such as a
medically required surgical removal of the uterus or a lesion of the endometrial wall following cancer treatment, could be targeted with stem cell-based
uteri. Patient-derived primary cells could be expanded in vitro, and seeded onto a de-cellularised donor uterus in order to avoid immune reaction of the
patient following re-grafting of the donor uterus. Patient primary cell culture on a scaffold allows to obtain a cellularised grafting patch which can be
transplanted to reconstitute the patient’s uterus.
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hydrogel channels within printed constructs effectively allows the
formation of vasculature147–150. Another exciting approach
entails sacrificial networks, which are cell matrices with embed-
ded dissolvable filaments. Upon the breakdown of these filaments,
the created space can be seeded with endothelial cells to generate
defined vasculature151–155. In the future, sacrificial networks may
be routinely combined with print-based approaches155,156
(reviewed in refs. 98,157). A limitation of explicit engineering of
vasculature is the decreased complexity of branching compared to
natural systems. Alternative approaches include seeding of vas-
cularised cell aggregates96,97 onto a basal scaffolding on which
subsequent layers of stromal and epithelial cell-laden gels or
organoid-containing gels are deposited (Fig. 5b). To increase
parallelisation for screening purposes, constructs could feasibly be
engineered over micro-patterned plates158,159, or alternatively by
the embedding of multiple vascularised endometrial organoids
within gels that then provide the appropriate signals for invasion
(Fig. 5b). A key advantage of print-based approaches is the
flexible inclusion of localised signalling by incorporation of che-
mically laden microbeads within gels, e.g., angiogenic signals to
promote vasculogenesis or angiogenesis, or candidate signals to
modulate trophoblast invasion.
Functional models of the uterus in different primate systems
could be applied to interrogate species-specific differences in the
mode of invasion, specifically allowing comparative studies of
superficial versus interstitial implantation. Optimisation of such
models to allow long-term survival of stem cell-based embryos
will provide a powerful asset for investigating the causes of first
trimester miscarriages.
Microfluidic “organ-on-a-chip” concepts157,160–162 in which
cell-aggregates or primary sample tissues from a specific organ
are cultured within a microfluidic device represent an alternative
platform for modelling of the uterus162 (Fig. 5c). In particular,
endometrium-on-a-chip has been used to combine primary
human stromal cells with epithelial cells to allow hormone-
responsive differentiation of stromal cells into decidua163. An
important advantage of custom microfluidic devices is the ability
to co-culture different cells or cell aggregates at an interface whilst
exerting precise control over the signalling environment. This is
exemplified in the recent generation of embryonic disc-like and
amnion-like cells in structures reminiscent of the early human
post-implantation embryo164. Modifications of these microfluidic
devices would allow for co-culture of layers of endometrial
stromal and endometrial epithelial cells, alongside trophoblast
cells, each with cell-specific signalling environments. This
approach could be used to monitor trophoblast invasion into
endometrium on-a-chip (Fig. 5c).
Modularity is one of the key strengths of microfluidic devices.
This was recently shown in a model of the female reproductive
tract by linear integration of chips containing tissues from fal-
lopian tubes, the uterus, and cervix with shared perfusion
between modules165. This system supported murine ovarian fol-
licles to produce the human 28-day menstrual cycle and
demonstrated the feasibility of modelling complex multi-cellular
behaviour by integrating a system of simpler component parts.
Extensions of this experimental setup may be of particular use in
disease modelling e.g., to test hypotheses about the mechanisms
of endometriosis52. The linear combination of a chip with
endometrial tissues alongside chips containing other tissues with
a shared circulating perfusion should provide a powerful assay to
gauge retrograde menstruation under hormone varying envir-
onments using cells from patients with and without endome-
triosis. Complex parallel arrays may provide further flexibility, for
example allowing a culture of endometrial cancer samples with
downstream samples of disease-free endometrium and adjacent
organ tissues and one-way connective perfusion, which could be
used to investigate metastasis of cancer. Indeed, a single meta-
static tumour sample could be connected to multiple identical
downstream tissue samples, each with different drug treatment,
thus allowing parallelised tissue-specific drug screening (Fig. 5c).
Re-cellularisation of in vivo-derived tissue scaffolds
A variety of uterine conditions require surgical interventions,
including complications during pregnancy. In some cases, pre-
vious surgical procedures, including caesarean sections, may
impact the ability of the uterus to support a foetus to full term or
serve as an aggravating factor in other uterine conditions47–49.
Stem cell-based models may provide a starting basis for regen-
erative approaches to address these issues.
Partial reconstruction of the uterus has been achieved using
tissue grafts166 or xenogeneic tissue grafts167. A recent study in
rabbits restored the function of rabbit uteri following extensive
excision of the endometrium using a biodegradable polymer
scaffold seeded with autologous primary cells168 (Fig. 5d). This
approach yielded increased implantation rates and sustained
pregnancy to term, in contrast to unseeded scaffolds or no-
scaffold controls. Whilst graft-based approaches may prove useful
for the repair of the uterus following trauma, they cannot address
severe pathologies where a hysterectomy may be required. Uterus
transplantations are one possibility169–172 and have allowed
successful livebirths173–175. However, transplantations are limited
by the availability of organ donors. Alternatively, recellularisation
approaches in which appropriate cell lineages are seeded onto
decellularised scaffolds, have been developed in animal models
for lungs176–180 (reviewed in ref. 181), heart182–184, liver185,
oesophagus186, trachea187, bladder172,188, liver189, and vagina190.
Decellularisation of rat and pig uteri has been shown to preserve
vasculature191,192, and allow for preliminary recellularisation
using neonatal rat uterine cells and rat mesenchymal stem cells192
or mixtures of stromal and epithelial stem cells from human
endometrial origin191. Studies in sheep have systematically
compared different decellularisation approaches of uteri for their
ability to support recellularisation of sheep PSCs189. The possi-
bility of using animal scaffolds presents an opportunity for clin-
ical settings (Fig. 5d). However, notable issues associated with the
removal of xenoantigens and risks of transmission of animal
viruses remain193. Finally, the ability of donor uteri from
deceased patients to sustain live births174 may open up the pos-
sibility of donor scaffolds. Together, these early studies suggest
that repair or reconstruction of uteri using pathogen-free, patient-
specific cells may represent a long-term treatment solution to
some of the most severe uterine pathologies.
Outlook
Investigation of the earliest stages of implantation and
maternal–embryo interactions with human embryos has long
been limited by the 14-day rule194. Stem cell-based approaches to
mimic the maternal environment synergise with recent advances
in modelling embryogenesis124, and together will illuminate the
critical stages of human periimplantation development. Model-
ling primate implantation with stem cell-based uteri is charged
with biomedical potential and provides a unique opportunity for
basic science. The development of multi-organoid systems and
controlled structural assembly of uterus models should facilitate
large-scale genetic and drug screening, enable cross-species
comparative studies, and shed new light in the field of human
embryogenesis that has previously been obscured. Stem cell-based
uterus and embryo research will raise important ethical questions
that will require careful consideration by the research community
and beyond. Ultimately, advances in basic science go hand-in-
hand with progress in clinical applications, and the next few years
REVIEW ARTICLE COMMUNICATIONS BIOLOGY | https://doi.org/10.1038/s42003-021-02233-8
8 COMMUNICATIONS BIOLOGY |           (2021) 4:749 | https://doi.org/10.1038/s42003-021-02233-8 | www.nature.com/commsbio
promise to see striking steps forward in the advancement of
women’s reproductive health.
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